Table 3.
Adjusted per-month per-patient utilization risk ratios associated with PP utilization over 12 months post-index
| Cost parameter | Estimate | Wald 95 % confidence limits | ProbChiSq | |
|---|---|---|---|---|
| Lower | Upper | |||
| All-cause utilization | ||||
| Any inpatient admission | 0.6441 | 0.5954 | 0.6967 | <0.0001 |
| Any emergency department visit | 0.8228 | 0.7892 | 0.8468 | 0.0134 |
| Mental health-related utilizationa | ||||
| Any inpatient admission | 0.6235 | 0.5731 | 0.6779 | <0.0001 |
| Any emergency department visit | 1.0539 | 0.9491 | 1.1587 | 0.1883 |
Calculated from odds ratios on a logit scale and adjusted for the covariates shown in Table 1
PP paliperidone palmitate
aIncludes claims with a primary diagnosis of ICD-9 290.xx–319.xx